12th World Congress Program - 7 June, 2015 Preconference (Preliminary) (Download PDF)PDF

Saturday 6 June (Preconference) | Sunday 7 June (Preconference) | Congress Program 8-11 June | Congress page | Congress News Center

SUNDAY 7 JUNE  
 

Understanding the Mechanisms of Action (MoA) of Neurostimulation and Spinal Cord Stimulation (SCS) Responder Identification

 

What Do We Know Now About Mechanism of Action in SCS?

08:45-08:50


Welcome and Introduction


Elliot Krames, MD, Simon Thomson, MBBS

08:50-09:05


An Overview of Neurophysiological Mechanisms of SCS


Michelangelo Buonocore, MD

09:05-09:20


The Neurochemistry of SCS in Neuropathic Pain


Bengt Linderoth, MD, PhD

09:20-09:35


The Dynamic Neurophysiological Measures of SCS


John Parker, PhD

09:35-09:50


The Neurophysiology of SCS in Neurocardiology (Ischaemia, Dysrhythmmia and Heart Failure)


Robert Foreman, PhD

09:50-10:05


The Segmental Neurophysiological Mechanisms for Pain Inhibition from SCS


Yun Guan, MD, PhD

10:05-10:20


A Knowledge‐Based SCS System Providing Maximum Pain Relief Without Extensive Testing


Jan Holsheimer, PhD

10:20-10:35


Q&A Discussion


10:35-10:55

Coffee Break

 

Variants of Standard SCS

11:00-11:15


What is Burst? Rationale?


Dirk de Ridder, MD, PhD

11:15-11:30


High Frequency Neurostimulation: Insights into Mechanisms


Kerry Bradley, PhD

11:30-11:45


DRG Stimulation – Differences to Standard SCS


Elliot Krames, MD

11:45-12:00


Subthreshold Spinal Cord Stimulation: Proven and Proposed Mechanisms


James North, MD

12:00-12:30


What Do We Still Need to Know About MoA of SCS?
Moderators – Elliot Krames, Simon Thomson
John Parker
Michelangelo Buonocore
Bengt Linderoth
Robert Foreman
Yun Guan

12:30 - 13:30


Lunch Break

 

Translation Into the Clinical Perspective

13:35-13:55


Evaluation of Preclinical Pain Models: Somatic vs. Visceral 


Professor Fernando Cervero, MD, PhD

13:55-14:15


Clinical History, Detailed Examination and Neurophysiological Investigations that Predict SCS Outcome - Can We Do Without SCS Trials in Some Patients?


Andrei Brinzeu, MD

14:15-14:35


Quantitative Sensory Testing: Can We Diagnose?


Dr. Vivek Metha

14:35-14:55


Machine Learning Approaches for the Detection of Acute and Chronic Pain: Promises and Limitations


Sean Mackey, MD, PhD

14:55-15:10


Q&A Discussion


15:10 - 15:30


Tea Break

 

Disease Markers as Predictors of SCS outcome (Panel Discussion)
Moderators – Elliot Krames, Simon Thomson

15:30-15:40


Clinical Markers Review


Tracy Cameron, PhD

15:40-15:50


Quantitative Sensory Testing


Dr. Vivek Metha

15:50-16:00


fMRI


Sean Mackey, MD, PhD

16:00-16:10


ECAPS


John Parker, PhD

16:10-16:30


Q&A Discussion


 


Last Updated on Tuesday, September 04, 2018 04:28 PM